The 40th Euro Congress on Cancer Science and Therapy is planned to be conducted in the month of May 25-26, 2020 at Rome, Italy. This Conference is CME & CPD Accredited. Cancer Science 2020 will be organized around the theme “Strengthening the future to fight against cancer”.

Cancer Science 2020 includes prompt Keynote presentations, Oral talks, Poster presentations and Exhibitions. The purpose of Cancer Science Conference is to promote interest, stimulate research, and promulgate information on all aspects of cancer science. This event will provide an unparalleled prospect to get associated with leading oncologists, doctors, scientists, academicians, specialists & business associates coming from all over the world.

Why to attend???

This meeting will have two days of discussions on methods and strategies related to management, quality improvement of Cancer as well as to explore the new ideas and concepts on Prevention, Diagnosis, and Treatment of the Organ-related Cancers and its innovative techniques. It gives a chief interdisciplinary stage to experts, professionals and teachers to display and discuss about the latest developments in the fields of Clinical Oncology and Molecular Diagnostic Techniques. It is crucial for oncologists to keep updated of the novel advancements in oncology and management of cancer. It enhances the cancer research with goal of increasing cure rates.

Target Audience:

• Doctors
• Scientists 
• Oncology  professionals
• Young  research  fellows
• Research Scholars
• Residents, Fellows & Post Docs
• Students
• Business Executives & Directors
• Cancer Experts
• Advertising Agency Executives
• Industry professionals

Market analysis:

Cancer is a disease characterized by the abandoned growth and spread of abnormal cells. If the growth of abnormal cells is not controlled, it can result in death. In Worldwide, one in seven deaths is due to cancer.  Cancer causes more deaths than AIDS, tuberculosis, and malaria. According to income when countries are grouped, cancer is the second leading cause of death in high-income countries (following cardiovascular diseases) and the third leading cause of death in low- and middle-income countries (following cardiovascular diseases and infectious and parasitic diseases).

Cancer Diagnostics Market:

The global market size of cancer diagnostics is expected to reach $22.7 billion from $7.1 billion in 2015. Growing prevalence of oncologic cases, constant technological innovations in diagnostics, and increasing requirement for effective screening tests are some of the main factors prompting the demand for screening tools across the world.

Rising awareness and supportive government enterprises are some other factors that are anticipated to increase the growth of the sector during the forecast period. The global cancer diagnostics market is fragmented based on technology, application, and region.  Increase in aging population and cancer cases are likely to create huge opportunity for cancer diagnostics.

Cancer Diagnostic Market, By Technology

 On the basis of technology, the cancer diagnostics market is divided into instrument-based and platform-based. In 2015, the instrument-based segment is predicted to account for a major share of the cancer diagnostics market, by product.

1) Platform Based:

• In situ Hybridization
• Flow Cytometry
• Next-generation Sequencing
• Microarrays
• Others

2) Instrument Based:

• Biopsy
• Mammography
• PET
• Ultrasound
• MRI
• CT

Cancer Diagnostic Market, By Application

Based on the application, the diagnostics market is fragmented into breast cancer, lung cancer, colorectal cancer, melanoma, Leukaemia and others. Breast cancer application is expected to account for a major portion of the cancer diagnostics market.

Cancer Diagnostic Market, By Region

Based on region, the cancer diagnostics market is classified into North America, Europe, Asia, and Rest of the World. Rest of the World includes Latin America, Pacific countries, and Middle East and Africa. North America is predicted as the largest share in the cancer diagnostics market, followed by Europe and Asia.

Best Regards         
Ritu Pal | Program Director        
Cancer Science 2020
Contact Number:  +448000148923
Email:   cancerscience@brainstormingmeetings.com    
Website:   https://cancerscience.insightconferences.com/